Reg Operations: Why Rules-Based Systems Are Better Than AI Alone

From regulatory submission management and document classification to product information management and regulatory intelligence, AI offers significant opportunities. However, pharmaceutical Regulatory Operations function within highly regulated environments where accuracy, consistency, traceability, data integrity and compliance are essential.

Although AI can process large volumes of information and identify patterns, it does not always guarantee consistent or predictable outcomes. Rules-based systems, on the other hand, operate using predefined business logic, approved regulatory requirements and controlled validation criteria.

For pharmaceutical Regulatory Operations, rules-based systems provide a more reliable foundation than relying on AI alone.

A rules-based system applies predefined business rules, regulatory requirements and validation conditions to automate operational processes. In Regulatory Operations, these systems can support submission completeness checks, mandatory metadata validation, document classification, product registration verification, country-specific requirements and regulatory milestone tracking.

The key advantages include:

Consistency and Predictability

Regulatory processes require consistent application of approved procedures. AI models may produce different outputs for similar inputs depending on context, prompts or model versions. Rules-based systems apply the same predefined conditions consistently, reducing variability and individual interpretation.

For example, a submission validation system can consistently identify missing mandatory documents and metadata before a regulatory package progresses to the next stage.

Regulatory Compliance and Auditability

Pharmaceutical companies must demonstrate that regulatory processes are controlled, documented and compliant with applicable requirements.

Rules-based systems support this through documented business rules, version control, traceable execution records, reproducible validation outcomes and defined approval mechanisms. Every validation result can be linked to an approved rule.

This makes it easier to explain decisions, investigate exceptions, and demonstrate compliance during audits and inspections.

Data Integrity and Accuracy

Regulatory information flows across multiple systems, including Regulatory Information Management Systems (RIMS), document management platforms and product databases.

Rules-based systems can enforce mandatory field completion, standardised formats, duplicate detection, referential integrity and consistency between connected systems.

AI can identify potential discrepancies, but rules-based validation provides stronger controls for enforcing mandatory data requirements and preventing incomplete or inconsistent records from progressing.

Transparency and Controlled Change Management

Rules-based systems provide transparency by linking validation outcomes to specific business rules and conditions.

They also support structured management of regulatory changes through impact assessments, rule updates, testing, approvals, effective dates and version history.

This is particularly important when regulatory requirements change across markets and jurisdictions.

Reduced Hallucination Risk

AI systems can generate information that appears correct but is not supported by regulatory source documents.

In pharmaceutical regulatory operations, this may result in Incorrect interpretation of regulatory requirements, Inaccurate submission metadata, Incorrect country-specific requirements.

The future of Pharmaceutical Regulatory Operations is not AI alone. It is AI-enabled, rules-governed and human-supervised automation.

The ultimate objective is to build regulatory operations that are efficient, accurate, explainable, compliant and inspection-ready.